AWARDBPA CALLOther than small business
BPA call 75F40124F19093EAGLE HILL CONSULTING, LLC
Overview
Award facts
- Net obligations
- $540.33K
- $540,329of $540.33K potential value
- Outlays (paid to date)
- $529.15K
- $529.15K paid of $540.33K obligated$529,153
- Period of performance
- Mar 11, 2024 to Mar 19, 2025
- Ended
- Modifications
- 1
- Latest action May 22, 2025
- Contract type
- BPA call
- PIID 75F40124F19093
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) OFFICE OF THE CENTER DIRECTOR, CONTROLLED SUBSTANCES STRATEGIC SUPPORT
Dates and value
- Award date
- Signed on Mar 11, 2024
- Potential end of performance
- Mar 18, 2025
- Current value
- $540,329Base and exercised options
- Potential value (if all options are exercised)
- $540,329
- Parent contract vehicle
- 75F40122A00009 (BPA, single award) — 90 orders recorded under it
Obligations by fiscal year of action
- FY2024: $540,329
Total across 1 fiscal year: $540,329
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 22, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationARLINGTON, VA
UEIPEGRG88NN3T8
CAGE code3JZZ8
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyEAGLE HILL CONSULTING LLC
Business types and certifications
Women-ownedFor-profit organizationLimited liability companyCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugsProgram activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Arlington, Virginia 22202-3418
- Congressional district (place of performance)
- VA-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- R406SUPPORT- PROFESSIONAL: POLICY REVIEW/DEVELOPMENT (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Labor hoursZ
Contract details
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Mar 11, 2024Base obligation at award: $540,329
- Latest action
- May 22, 2025 — Other administrative actionModification P00001; administrative: no change in scope or value
- Actions by type
- Base award1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Closely associated,critical functionsCL,CT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- BPA callA
- Parent vehicle type
- BPAE
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2024/2024-0600-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression